首页> 外国专利> SHORT PEPTIDE ATR001, MONOCLONAL ANTIBODY PREPARED BY SHORT PEPTIDE AND HAVING FUNCTION OF BIASED REGULATION OF AT1R, AND APPLICATION THEREOF

SHORT PEPTIDE ATR001, MONOCLONAL ANTIBODY PREPARED BY SHORT PEPTIDE AND HAVING FUNCTION OF BIASED REGULATION OF AT1R, AND APPLICATION THEREOF

机译:短肽ATR001,由短肽制备的单克隆抗体,具有AT1R的偏置调节作用及其应用

摘要

A short peptide ATR001, a monoclonal antibody that is prepared by a short peptide and that has a function of the biased regulation of AT1R, and an application thereof; the short peptide ATR001 has an amino acid sequence of AFHYESQ, a hybridoma cell CQ8-A2D9, and a storage number thereof is: CCTCC NO: C2017108. Monoclonal antibody technology is used to prepare a monoclonal antibody targeting AT1R, and the antibody may have a function of the biased regulation of AT1R, having a therapeutic effect in vascular remodeling diseases such as hypertension, atherosclerosis and aneurysms.
机译:一种短肽ATR001,一种由短肽制备且具有AT1R的调控调控功能的单克隆抗体及其应用;短肽ATR001具有AFHYESQ的氨基酸序列,杂交瘤细胞CQ8-A2D9,并且其存储号为:CCTCC NO:C2017108。单克隆抗体技术用于制备靶向AT1R的单克隆抗体,该抗体可能具有AT1R调控的偏向功能,对诸如高血压,动脉粥样硬化和动脉瘤等血管重塑疾病具有治疗作用。

著录项

  • 公开/公告号WO2019047921A1

    专利类型

  • 公开/公告日2019-03-14

    原文格式PDF

  • 申请/专利号WO2018CN104608

  • 发明设计人 CHEN XIAO;

    申请日2018-09-07

  • 分类号C07K16/28;C07K7/14;C12N5/20;A61P9/10;A61P9/12;

  • 国家 WO

  • 入库时间 2022-08-21 11:56:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号